Actively Recruiting
A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity
Led by Novo Nordisk A/S · Updated on 2026-02-27
96
Participants Needed
1
Research Sites
47 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is testing a new medicine, NNC6989-0001, to test it is safe and tolerable for healthy people living with overweight or obesity. NNC6989-0001 is still being tested in studies and is not yet available for prescription by doctors. In this study, participants will receive either NNC6989-0001 or a placebo; which treatment each participant receives will be decided by chance.
CONDITIONS
Official Title
A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female of non-childbearing potential
- Age 18 to 55 years at the time of informed consent
- Body mass index (BMI) of 25.0 to 34.9 kg/m² for Part A or 25.0 to 39.9 kg/m² for Part B
- Eligible based on medical history, physical exam, vital signs, ECG, and lab tests as judged by the investigator
You will not qualify if you...
- Any condition that might risk participant safety or study compliance as judged by the investigator
- Clinically significant body weight change (5% or more) or dieting attempts within 90 days before screening
- Treatment with any GLP-1 receptor agonist or medication with GLP-1 activity within 90 days before screening
- Use of prescription or non-prescription medicines within 14 days before screening except routine multivitamins or occasional acetaminophen/NSAIDs for mild pain
- Use of other non-prescription supplements such as high-dose vitamins or weight-loss supplements not permitted
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
ICON Early Phase Services, LLC
Lenexa, Kansas, United States, 66219
Actively Recruiting
Research Team
N
Novo Nordisk
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here